Arrowhead Research Corporation (ARWR) to Present at Upcoming Scientific Conferences
6/14/2013 7:02:53 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, today announced that the company will present data on the Dynamic PolyConjugate™ (DPC) siRNA delivery system and the ARC-520 hepatitis B drug candidate at three upcoming scientific conferences.
Help employers find you! Check out all the jobs and post your resume.